SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-16-004208
Filing Date
2016-04-14
Accepted
2016-04-13 19:29:54
Documents
75
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K entiabiosciences10k123115.htm 10-K 1655273
2 EX-3.1 ex3-1.htm EX-3.1 77633
3 EX-31.1 ex31-1.htm EX-31.1 15782
4 EX-31.2 ex31-2.htm EX-31.2 16164
5 EX-32.1 ex32-1.htm EX-32.1 6189
6 EX-32.2 ex32-2.htm EX-32.2 5309
13 GRAPHIC logo.jpg GRAPHIC 4565
  Complete submission text file 0001185185-16-004208.txt   6632215

Data Files

Seq Description Document Type Size
7 EX-101.INS ergo-20151231.xml EX-101.INS 1239156
8 EX-101.SCH ergo-20151231.xsd EX-101.SCH 64504
9 EX-101.CAL ergo-20151231_cal.xml EX-101.CAL 37799
10 EX-101.DEF ergo-20151231_def.xml EX-101.DEF 354634
11 EX-101.LAB ergo-20151231_lab.xml EX-101.LAB 449236
12 EX-101.PRE ergo-20151231_pre.xml EX-101.PRE 352658
Mailing Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140
Business Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140 844-559-9910
Entia Biosciences, Inc. (Filer) CIK: 0001408299 (see all company filings)

IRS No.: 260561199 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52864 | Film No.: 161570203
SIC: 2833 Medicinal Chemicals & Botanical Products